COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1965: Articles 19641-19650  | Next

The first wave of the Spanish COVID-19 epidemic was associated with early introductions and fast spread of a dominating genetic variant
Lopez, M. G., Chiner-Oms, A., Garcia de Viedma, D., Ruiz-Rodriguez, P., Bracho, M. A., Cancino-Munoz, I., Dauria, G., de Marco, G., Garcia-Gonzalez, N., Goig, G. A., Gomez-Navarro, I., Jimenez-Serrano, S., Martinez-Priego, L., Ruiz-Hueso, P., Ruiz-Roldan, L., Torres-Puente, M., Alberola, J., Albert, E., Aranzamendi Zaldumbide, M., Bea-Escudero, M. P., Boga, J. A., Bordoy, A. E., Canut-Blasco, A., Carvajal, A., Cilla Eguiluz, G., Cordon Rodriguez, M. L., Costa-Alcalde, J. J., de Toro, M., de Toro Peinado, I., del Pozo, J. L., Duchene, S., Ferandez, J., Fuster Escriva, B., Gimeno Cardona, C., Gonzalez Galan, V., Gonzalo Jimenez, N., Hernaez Crespo, S., Herranz, M., Lepe, J. A., Lopez-Hontangas, J. L., Marcos, M. A., Martin, V., Martro, E., Milagro Beamonte, A., Montes Ros, M., Moreno-Munoz, R., Navarro, D., Navarro-Mari, J. M., Not, A., Oliver, A., Palop-Borras, B., Parra Grande, M., Pedrosa-Corral, I., Perez Gonzalez, M. C., Perez-Lago, L., Pineiro Vazquez, L., Rabella, N., Reina, J., Rezusta, A., Robles Fonseca, L., Rodriguez-Villodres, a., Sanbonmatsu-Gamez, S., Sicilia, J., Tirado Balaguer, M. D., Torres, I., Tristancho, A., Marimon, J. M., SeqCOVID-Spain consortium, , Coscolla, M., Gonzalez-Candelas, F., Comas, I.
10.1101/2020.12.21.20248328 — Posted: 2020-12-22
Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review
Hayward, S. E., Deal, A., Cheng, C., Crawshaw, A. F., Orcutt, M., Vandrevala, T. F., Norredam, M., Carballo, M., Ciftci, Y., Requena-Mendez, A., Greenaway, C., Carter, J., Knights, F., Mehrotra, A., Seedat, F., Bozorgmehr, K., Veizis, A., Campos-Matos, I., Wurie, F., Noori, T., McKee, M., Kumar, B., Hargreaves, S.
10.1101/2020.12.21.20248475 — Posted: 2020-12-22
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
Tea, F., Ospina Stella, A., Aggarwal, A., Darley, D. R., Pilli, D., Vitale, D., Merheb, V., Lee, F. X. Z., Cunningham, P., Walker, G. J., Brown, D. A., Rawlinson, W. D., Isaacs, S. R., Mathivanan, V., Hoffman, M., Poehlmann, S., Dwyer, D. E., Rockett, R., Sintchenko, V., Hoad, V. C., Irving, D. O., Dore, G. J., Gosbell, I. B., Kelleher, A. D., Matthews, G. V., Brilot, F., Turville, S. G.
10.1101/2020.12.19.20248567 — Posted: 2020-12-22
Identification of SARS-CoV-2-specific immune alterations in acutely ill patients
Rebillard, R.-M., Charabati, M., Grasmuck, C., Filali-Mouhim, A., Tastet, O., Brassard, N., Daigneault, A., Bourbonniere, L., Balthazard, R., Carmena Moratalla, A., Carpentier Solorio, Y., Farzam-kia, N., Fournier, A. P., Gowing, E., Jamann, H., Lemaitre, F., Mamane, V. H., Thai, K., Cailhier, J.-F., Chomont, N., Finzi, A., Chasse, M., Durand, M., Arbour, N., Kaufmann, D. E., Prat, A., Larochelle, C.
10.1101/2020.12.21.20248642 — Posted: 2020-12-22
COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting
JASSAT, W., Cohen, C., Masha, M., Goldstein, S., Kufa-Chakezha, T., Savulescu, D., Walaza, S., Bam, J.-L., Davies, M.-A., Prozesky, H. W., Naude, J., Mnguni, T., Lawrence, C. A., Mathema, H., Blumberg, L.
10.1101/2020.12.21.20248409 — Posted: 2020-12-22
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
Yang, S., Li, Y., Dai, L., Wang, J., He, P., Li, C., Fang, X., Wang, C., Zhao, X., Huang, E., Wu, C., Zhong, Z., Wang, F., Duan, X., Tian, S., Wu, L., Liu, Y., Luo, Y., Chen, Z., Li, F., Li, J., Yu, X., Ren, H., Liu, L., Meng, S., Yan, J., Hu, Z., Gao, L., Gao, G. F.
10.1101/2020.12.20.20248602 — Posted: 2020-12-22 Discussion: Offsite
Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC WHO Clinical Characterisation Protocol prospective multicentre observational cohort study
Docherty, A. B., Mulholland, R. H., Lone, N. I., Cheyne, C. P., De Angelis, D., Diaz-Ordaz, K., Donoghue, C., Drake, T. M., Dunning, J., Funk, S., Garcia-Finana, M., Girvan, M., Hardwick, H. E., Harrison, J., Ho, A., Hughes, D. M., Keogh, R. H., Kirwan, P. D., Leeming, G., Nguyen-Van-Tam, J. S., Pius, R., Russell, C. D., Spencer, R., Tom, B. D., Turtle, L., Openshaw, P. J., Baillie, J. K., Harrison, E. M., Semple, M. G.
10.1101/2020.12.19.20248559 — Posted: 2020-12-22
Predicting intention to receive COVID-19 vaccine among the general population using the Health Belief Model and the Theory of Planned Behavior Model
Shmueli, L.
10.1101/2020.12.20.20248587 — Posted: 2020-12-22
Immunogenicity and crossreactivity of antibodies to SARS-CoV-2 nucleocapsid protein
Dobano, C., Santano, R., Jimenez, A., Vidal, M., Chi, J., Rodrigo Melero, N., Popovic, M., Lopez-Aladid, R., Fernandez-Barat, L., Tortajada, M., Carmona-Torre, F., Reina, G., Torres, A., Mayor, A., Carolis, C., Garcia-Basteiro, A. L., Aguilar, R., Moncunill, G., Izquierdo, L.
10.1101/2020.12.19.20248551 — Posted: 2020-12-22
Development and Evaluation of Two Rapid Indigenous IgG-ELISA immobilized with ACE-2 Binding Peptides for Detection Neutralizing Antibodies Against SARS-CoV-2
Sil, B. K., Adnan, N., Oishee, M. J., Ali, T., Jahan, N., Khandker, S. S., Kobatake, E., Mie, M., Khondoker, D. M. U., Haq, M. A., Jamiruddin, M. R.
10.1101/2020.12.19.20248535 — Posted: 2020-12-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).